Recommended Pages at stemcellassays.com
Stem Cell Autopsy – a collection of clinical cases | Stem Cell Assays
stemcellassays.com — “More than 2 years ago I’ve started to collect a clinical cases of pathology (autopsy/ biopsy), from the patients who underwent cell therapy procedures. Initially I intended to cover only “stem cell therapy”, but later extended to all “cell therapies”.” View full resource at stemcellassays.com
Most Recently Shared on May 13, 2012 at 1:03 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Stem Cell Autopsy – a collection of clinical cases http://t.co/ZxFJmdvp
Clinical cell processing news – part 1 | Stem Cell Assays
stemcellassays.com — “In the new series of posts I’d like to review recent advances in clinical cell processing. In this series I’ll overview a literature and focus on some particular techniques. 1. Production and process of platelet lysate for MSC expansion (Cytotherapy)” View full resource at stemcellassays.com
Most Recently Shared on May 11, 2012 at 1:21 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Clinical cell processing news – part 1 - In the new series of posts I'd like to review recent advances i... http://t.co/ozYHqT1b
Trainings and courses in regenerative medicine | Stem Cell Assays
stemcellassays.com — “We’ve written about educational programs at universities and it was one of the most popular our posts. Professionals and young people have a great interest to education and career development in regenerative medicine. Today, we will focus on Master’s degree” View full resource at stemcellassays.com
Most Recently Shared on May 9, 2012 at 1:24 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Trainings and courses in regenerative medicine - We've written about educational programs at universitie... http://t.co/Hducl9Tc
Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells | Stem Cell Assays
stemcellassays.com — “Arnold Caplan is a scientist, who coined a term “mesenchymal stem cells” in 1991 for the type of bone marrow cells, previously known as “stromal stem cells”. This term became widely adopted. He gave a very interesting talk during plenary” View full resource at stemcellassays.com
Most Recently Shared on May 8, 2012 at 1:16 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells http://t.co/C7ApM0GW
Isolation of nasal olfactory stem cells – video protocol | Stem Cell Assays
stemcellassays.com — “Collection of free stem cell video protocols from JoVE. Isolating Nasal Olfactory Stem Cells from Rodents or Humans Stéphane D. Girard1, 2, Arnaud Devéze3, Emmanuel Nivet1, 2, 4, Bruno Gepner5, François S. Roman2, François Féron1, 61NICN, Aix Marseille University, 2LNPM,” View full resource at stemcellassays.com
Most Recently Shared on September 12, 2011 at 12:37 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Isolation of nasal olfactory stem cells – video protocol http://t.co/L1q7EnI
Characterization of human cells for clinical applications | Stem Cell Assays
stemcellassays.com — “Department for Business Innovation & Skills (UK) just released a guidelines for characterization of human cells: Publicly Available Specification (PAS) 93 is a best practice guide for organisations that develop products for clinical applications, using human cells as their building” View full resource at stemcellassays.com
Most Recently Shared on September 11, 2011 at 12:35 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Characterization of human cells for clinical applications http://t.co/mwcucjp
How to remove residual undifferentiated pluripotent stem cells from mixed cell populations | Stem Cell Assays
stemcellassays.com — “It is well known that pluripotent stem cells (embryonic stem and iPS cells) possess a great propensity to spontaneous tumorigenesis in vivo. In order to meet safety criteria, developers should guarantee an absence of residual undifferentiated pluripotent stem cells (PSC)” View full resource at stemcellassays.com
Most Recently Shared on September 10, 2011 at 12:44 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] How to remove residual undifferentiated pluripotent stem cells from mixed cell populations http://t.co/Wr5DIvC
Regenerative medicine industry – worthwhile investment or not? | Stem Cell Assays
stemcellassays.com — “One of the most commonly asked question from potential investors is: “Should we invest in regenerative medicine and stem cell companies?” There are so many companies right now, which are hardly dependent and/or begging for investment. This is a really” View full resource at stemcellassays.com
Most Recently Shared on September 8, 2011 at 12:51 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Regenerative medicine industry – worthwhile investment or not? http://t.co/tIgPikK
A protocol for direct reprogramming of fibroblasts into motor neurons | Stem Cell Assays
stemcellassays.com — “Direct transdifferentiation by defined factors (aka “direct reprogramming”) is an alternative to iPS cell technique for generation autologous therapeutic cells. The recent study, published in Cell Stem Cell journal, demonstrates that mouse and human fibroblasts could be converted directly into” View full resource at stemcellassays.com
Most Recently Shared on September 7, 2011 at 12:45 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] A protocol for direct reprogramming of fibroblasts into motor neurons http://t.co/9mqOibZ
True blood: Ex vivo production of red blood cells | Stem Cell Assays
stemcellassays.com — “Few days ago the first report about successful transplantation of in vitro generated red blood cells was published. This study establishes proof of principle for clinical transfusion ex vivo manufacturing blood. Using a culture protocol permitting erythroid differentiation from peripheral” View full resource at stemcellassays.com
Most Recently Shared on September 5, 2011 at 12:34 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] True blood: Ex vivo production of red blood cells http://t.co/Az2WCxZ
Organ on a chip concept explained | Stem Cell Assays
stemcellassays.com — “In this video, Professor Don Ingber explains the concept of “organ on a chip”. He uses recently developed “lung on a chip” device as an example. One more video from Wyss Institute: Related posts:Replacing body parts – the future of” View full resource at stemcellassays.com
Most Recently Shared on September 3, 2011 at 12:42 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Organ on a chip concept explained - In this video, Professor Don Ingber explains the concept of "organ o... http://t.co/N2XeCLw
Discussion: The value of colony-forming units assay in cord blood transplantation | Stem Cell Assays
stemcellassays.com — “LinkedIn groups is the only place online where you can find a lot of discussions about stem cell research, cell therapy and regenerative medicine. LinkedIn groups have reached critical mass for very productive and valuable daily discussions. There are few” View full resource at stemcellassays.com
Most Recently Shared on September 2, 2011 at 12:42 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Discussion: The value of colony-forming units assay in cord blood transplantation http://t.co/OIJVmvv
Safety assessment of adipose-derived stem cell product for clinical trials | Stem Cell Assays
stemcellassays.com — “I wrote before about some preclinical safety assays for human adipose-derived mesenchymal stem cells (AMSC). Few days ago I came across of very nice study, assessing safety of AMSC after intravenous administration in mice and human. The list of assays,” View full resource at stemcellassays.com
Most Recently Shared on August 31, 2011 at 12:44 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Safety assessment of adipose-derived stem cell product for clinical trials http://t.co/mPFEDjA
Culturing human retinoblastoma cells and propagation of tumors in immune deficient mice – video protocol | Stem Cell Assays
stemcellassays.com — “Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice Wesley S. Bond1, 2, Lalita Wadhwa2, 3, Laszlo Perlaky2, 3, Rebecca L. Penland4, Mary Y. Hurwitz2, 3, Richard L. Hurwitz2, 3, 5, 6,*, Patricia Chèvez-Barrios4, 6, 7,*1Interdepartmental Program in” View full resource at stemcellassays.com
Most Recently Shared on August 28, 2011 at 12:31 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Culturing human retinoblastoma cells and propagation of tumors in immune deficient mice – video protocol http://t.co/zjkoohr
Isolation, biodistribution and safety assessment of human adipose-derived mesenchymal stem cells | Stem Cell Assays
stemcellassays.com — “Human adipose tissue is a clinically significant source of stem and progenitor cells for therapies. There are many ongoing clinical trials, which involve adipose-derived stem cells. There is a variety of protocols for isolation different cell population from adipose tissue.” View full resource at stemcellassays.com
Most Recently Shared on August 27, 2011 at 12:37 am By:
Dr. M Salim Ismail MD CAM, Integrative Physician, Physician, and Doctor
[Technical] Isolation, biodistribution and safety assessment of human adipose-derived mesenchymal stem cells http://t.co/HV62m4p
